Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Glioma: Gliosarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableStudy completedNCT00897611
What this trial is testing

Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma

Who this might be right for
High Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 42
Early research (Phase 1)Study completedNCT00609999
What this trial is testing

Ph I Dasatinib + Erlotinib in Recurrent MG

Who this might be right for
GlioblastomaGliosarcoma
Duke University 47
Testing effectiveness (Phase 2)Study completedNCT00005855
What this trial is testing

Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium 48
Testing effectiveness (Phase 2)Ended earlyNCT01110876
What this trial is testing

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma Multiforme
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00064363
What this trial is testing

Talampanel in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Temporarily pausedNCT00003067
What this trial is testing

Biological Therapy in Treating Patients With Primary or Advanced Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT00004004
What this trial is testing

Procarbazine in Treating Patients With Recurrent Brain Tumor

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Study completedNCT00995007
What this trial is testing

Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 112
Large-scale testing (Phase 3)WithdrawnNCT00003564
What this trial is testing

Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002619
What this trial is testing

Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT01837862
What this trial is testing

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Who this might be right for
Pilomyxoid AstrocytomaPilocytic AstrocytomaGlioma, Astrocytic+9 more
Julie Krystal 10
Early research (Phase 1)Study completedNCT00979173
What this trial is testing

Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma

Who this might be right for
Glioma
Annick Desjardins 5
Testing effectiveness (Phase 2)WithdrawnNCT01740570
What this trial is testing

Phase I/II Cabazitaxel for Recurrent Malignant Glioma

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center
Not applicableEnded earlyNCT00471653
What this trial is testing

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Who this might be right for
Brain and Central Nervous System TumorsThrombocytopenia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10